5,6,7,7a,9,10,14b,14c- octahydro- 4- (2,3- O- (1- methylethylidene)- ribofuranosyl)cyclopenta(4,5)pyrimido(5',4':3,4)pyrrolo(2,1- a)isoquinoline- 1,3(2H,4H)- dione
structure given in first source
Networked: 0
relevant articles (0 outcomes,
0 trials/studies)
Bio-Agent Context: Research Results
- Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
- Pyrimidines: 510
- Pyrimidine Nucleosides: 50
- Uridine: 1186
- 5,6,7,7a,9,10,14b,14c-octahydro-4-(2,3-O-(1-methylethylidene)-ribofuranosyl)cyclopenta(4,5)pyrimido(5',4':3,4)pyrrolo(2,1-a)isoquinoline-1,3(2H,4H)-dione
- Fused-Ring Heterocyclic Compounds
- 2-Ring Heterocyclic Compounds
- Isoquinolines: 34
- 5,6,7,7a,9,10,14b,14c-octahydro-4-(2,3-O-(1-methylethylidene)-ribofuranosyl)cyclopenta(4,5)pyrimido(5',4':3,4)pyrrolo(2,1-a)isoquinoline-1,3(2H,4H)-dione
- Nucleic Acids, Nucleotides, and Nucleosides: 1
- Nucleosides: 6847
- Pyrimidine Nucleosides: 50
- Uridine: 1186
- 5,6,7,7a,9,10,14b,14c-octahydro-4-(2,3-O-(1-methylethylidene)-ribofuranosyl)cyclopenta(4,5)pyrimido(5',4':3,4)pyrrolo(2,1-a)isoquinoline-1,3(2H,4H)-dione
- Ribonucleosides: 49
- Uridine: 1186
- 5,6,7,7a,9,10,14b,14c-octahydro-4-(2,3-O-(1-methylethylidene)-ribofuranosyl)cyclopenta(4,5)pyrimido(5',4':3,4)pyrrolo(2,1-a)isoquinoline-1,3(2H,4H)-dione